Skip to content
SolAeroMed Inc. logo — company profile

SolAeroMed Inc.

Founded 2011 3 employees Seed Total: $101.04K Biotechnology, Health and Wellness +1

General Information

Company Name SolAeroMed Inc.
Founded Year 2011
Employees 3
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with SolAeroMed Inc.. To contact SolAeroMed Inc., visit solaeromed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SolAeroMed Inc. compare?

A PDF of SolAeroMed Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SolAeroMed Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SolAeroMed Inc.

SolAeroMed is a biotechnology and pharmaceutical startup with a focus on innovative healthcare solutions. Founded in 2011, the company has received a Seed Round investment from VA Angels on 01 September 2016. SolAeroMed's commitment to advancing medical technology and pharmaceuticals positions it as a promising venture in the healthcare industry. With a solid foundation and support from notable investors, the company is poised for growth and potential breakthroughs in the biotech and pharmaceutical sectors. This recent investment signifies a vote of confidence in SolAeroMed's vision and potential for impact in the healthcare market.

Business keywords: biopharmaceutical, therapeutics, obstructive lung diseases, cystic fibrosis, bronchiectasis, asthma rescue drug, chronic obstructive lung diseases, respiratory health, medical innovation, treatment development, pulmonary medicine, pharmaceutical research, drug development, respiratory therapy

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
VA Angels
01 Sep 2016
Seed Round Undisclosed 1
VA Angels
20 Mar 2016
Seed Round Undisclosed 1
VA Angels
03 Nov 2015
Venture Round $101.04K -
25 Nov 2013

SolAeroMed Inc. Alternatives & Competitors

View All Alternatives
SolAeroMed Inc. vs

A clinical-stage biotech company focusing on discovering, developing and commercializing inhalation...

Series C
3 employees
Biotechnology, Health Care
SolAeroMed Inc. vs
Savara Inc.
Savara Inc. United States

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases.

Post-IPO Equity
126 employees
Biopharma, Biotechnology
SolAeroMed Inc. vs

Driving advancements in respiratory health with innovative inhalable treatments.

Venture round
Biotechnology, Health Care

FAQ About SolAeroMed Inc.

Visit the post for more.
SolAeroMed Inc. was founded in 2011.
SolAeroMed Inc. operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceutical, therapeutics, obstructive lung diseases and cystic fibrosis.
SolAeroMed Inc. has approximately 3 employees.
SolAeroMed Inc. has completed 4 funding rounds, raising a total of $101.04K. The latest funding stage is Seed.
Top alternatives and competitors to SolAeroMed Inc. include Chance Pharmaceuticals 畅溪制药, Savara Inc., Corus Pharma, Avalyn Pharma, Orpro Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SolAeroMed Inc. and Chance Pharmaceuticals 畅溪制药 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SolAeroMed Inc., https://bouncewatch.com/company/solaeromed, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout